Diagnosing Drug Allergy: the T is the Key
NCT: NCT06409884 · RECRUITING
Brief Summary
The goal of this clinical trial is to validate a newly developed test in the diagnosis of patients with amoxicillin allergy (i.e. T-cell activation test). The main questions the study aims to assess are the reliability and applicability of this test. Participants will be asked to visit the hospital 1, 3 or 5 times during which blood is collected and when applicable, allergy skin testing is performed.
Frequently Asked Questions
What is Diagnosing Drug Allergy: the T is the Key?
Diagnosing Drug Allergy: the T is the Key is a clinical trial registered under NCT06409884. Current status: RECRUITING.
What is the status of NCT06409884?
The current status of NCT06409884 (Diagnosing Drug Allergy: the T is the Key) is: RECRUITING.
When did Diagnosing Drug Allergy: the T is the Key start?
Diagnosing Drug Allergy: the T is the Key started on 2024-05-21.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.